Understanding epilepsy
An epilepsy syndrome is more than a seizure type. It is a recognisable pattern of clinical and EEG features that tend to occur together and may also be supported by age at onset, genetics, imaging, development, triggers, comorbidities and the way the epilepsy changes over time.
Key point: seizure type, epilepsy type and epilepsy syndrome are three different levels of diagnosis. A syndrome diagnosis can sometimes tell clinicians more about likely treatment, investigations and prognosis than the name of an individual seizure alone.
Where syndromes fit into epilepsy diagnosis
The ILAE classification uses several diagnostic levels. First, clinicians identify the seizure type. They then consider the broader epilepsy type, such as focal or generalised epilepsy. When a characteristic pattern is present, a more specific epilepsy syndrome may be diagnosed.
Not every person with epilepsy can be given a named syndrome, and a syndrome diagnosis is not required for epilepsy to be real or valid. It is an additional level of precision when the clinical pattern fits recognised criteria.
What makes a syndrome a syndrome?
The ILAE describes an epilepsy syndrome as a characteristic cluster of clinical and EEG features, often supported by specific aetiological findings. Depending on the syndrome, important features can include:
- the age seizures begin
- the seizure types present
- the EEG pattern
- whether seizures occur mainly during sleep or on waking
- specific triggers
- MRI findings
- genetic or metabolic findings
- development, learning or behaviour
- associated neurological or psychiatric features
- how the epilepsy changes with age
- whether remission is expected
A syndrome is therefore a pattern, not a single test result.
Why identifying a syndrome matters
Recognising a syndrome can influence clinical decisions. It may help clinicians choose the most useful investigations, avoid medicines known to aggravate particular seizure types, select treatments with better evidence for that syndrome, decide when genetic testing is useful and give more accurate information about likely future course.
Some syndromes are relatively self-limited. Others are associated with drug-resistant seizures or important developmental, cognitive or behavioural effects and may require early tertiary specialist care.
Syndromes are often age-related
One of the strongest clues to an epilepsy syndrome is when it begins. The ILAE’s 2022 syndrome framework groups recognised syndromes broadly into those beginning in neonates and infants, those beginning in childhood, and those that can begin at a variable age. A separate position statement defines the idiopathic generalised epilepsy syndromes.
Age is important, but it is not used alone. The seizure pattern, EEG and other features still need to fit.
Syndromes beginning in neonates and infancy
Some epilepsy syndromes begin in the first days, months or two years of life. This group ranges from self-limited syndromes to severe developmental and epileptic encephalopathies.
Examples include self-limited neonatal epilepsy, self-limited familial neonatal-infantile epilepsy, early infantile developmental and epileptic encephalopathy, epilepsy of infancy with migrating focal seizures and Dravet syndrome.
The exact diagnosis matters because early-life epilepsies can have very different causes and treatment pathways. Some require urgent genetic, metabolic or specialist neurological investigation.
Syndromes beginning in childhood
The ILAE divides childhood-onset syndromes into several broad groups, including self-limited focal epilepsies, generalised epilepsies and developmental and/or epileptic encephalopathies.
Self-limited focal epilepsies
These include recognised syndromes such as self-limited epilepsy with centrotemporal spikes and self-limited epilepsy with autonomic seizures. The word “self-limited” means that the syndrome commonly remits with age; it does not mean seizures are unimportant or never require treatment.
Childhood generalised epilepsies
Examples include childhood absence epilepsy, epilepsy with myoclonic absence and epilepsy with eyelid myoclonia. These syndromes can share generalised EEG features but differ in seizure pattern, age, prognosis and treatment considerations.
Developmental and epileptic encephalopathies
This group includes syndromes such as epilepsy with myoclonic-atonic seizures and Lennox–Gastaut syndrome. In developmental and epileptic encephalopathies, developmental difficulties may arise from the underlying cause, epileptic activity, or both.
These are not simply “severe seizure types”. They are complex epilepsy disorders requiring syndrome-specific assessment and management.
Idiopathic generalised epilepsy syndromes
The ILAE recognises four classic idiopathic generalised epilepsy syndromes:
- childhood absence epilepsy
- juvenile absence epilepsy
- juvenile myoclonic epilepsy
- epilepsy with generalised tonic-clonic seizures alone
These syndromes share important generalised features, but they are not interchangeable. The age of onset, mix of seizure types, EEG pattern and long-term course differ.
Syndromes that can begin at a variable age
Some syndromes can begin in either younger or older people. ILAE examples include sleep-related hypermotor epilepsy, GEFS+ →, epilepsy with auditory features, familial mesial temporal lobe epilepsy, familial focal epilepsy with variable foci, epilepsy with reading-induced seizures and several other defined syndromes.
The variable-age group also includes a small number of aetiology-specific syndromes, including mesial temporal lobe epilepsy with hippocampal sclerosis and Rasmussen syndrome.
Individual syndrome guides
Dravet Syndrome →
Lennox–Gastaut Syndrome →
Childhood Absence Epilepsy →
Juvenile Myoclonic Epilepsy →
Self-Limited Epilepsy with Centrotemporal Spikes (SeLECTS) →
Self-Limited Epilepsy with Autonomic Seizures (SeLEAS) →
Juvenile Absence Epilepsy →
Epilepsy with Generalised Tonic-Clonic Seizures Alone →
Epilepsy with Eyelid Myoclonia →
Epilepsy with Myoclonic Absences →
Epilepsy with Myoclonic-Atonic Seizures →
D/EE-SWAS →
Infantile Epileptic Spasms Syndrome (IESS) →
Self-Limited Neonatal Epilepsy →
Self-Limited Familial Neonatal-Infantile Epilepsy →
Early Infantile Developmental and Epileptic Encephalopathy (EIDEE) →
Epilepsy of Infancy with Migrating Focal Seizures →
Myoclonic Epilepsy in Infancy →
Genetic Epilepsy with Febrile Seizures Plus (GEFS+) →
Epilepsy with Auditory Features →
Familial Mesial Temporal Lobe Epilepsy →
Familial Focal Epilepsy with Variable Foci →
Epilepsy with Reading-Induced Seizures →
A syndrome is not the same as a cause
An epilepsy syndrome and the underlying cause are complementary pieces of information. One syndrome may have several possible causes, while one genetic or structural cause can sometimes produce more than one epilepsy pattern.
This is why modern epilepsy assessment considers both the syndrome and the aetiology — structural, genetic, infectious, metabolic, immune or unknown — rather than treating them as competing labels.
Read more: Genetics & Epilepsy →
Syndromes can evolve over time
Epilepsy is not always static. The seizure pattern, EEG and developmental picture can change with age, and some people may meet criteria for one recognised syndrome early in life and a different syndrome later.
A syndrome diagnosis may also become clearer only after repeated seizures, sleep EEG, MRI, genetic testing or longer follow-up. Reclassification is not necessarily evidence that an earlier clinician was wrong; sometimes the defining features had not yet emerged.
Does everybody need genetic testing?
No. Genetic testing is targeted. It is particularly relevant when a genetic epilepsy is suspected, especially with very early onset, developmental difficulties, congenital abnormalities, a recognised genetic syndrome or otherwise unexplained epilepsy where identifying the cause could change management.
A syndrome can sometimes be diagnosed clinically without finding a single genetic cause, and “genetic” does not necessarily mean inherited from a parent.
Does the syndrome determine treatment?
It can strongly influence treatment, but it does not replace individual clinical judgement. Some antiseizure medicines have evidence for particular syndromes, while others may worsen certain seizure types. Some complex syndromes may also lead to consideration of ketogenic dietary therapy, surgery, neurostimulation or syndrome-specific medicines.
This is one reason accurate classification matters before treatment is repeatedly changed.
Read more: Treatment Options →
Why syndrome diagnosis can sometimes be difficult
Not every person fits a textbook pattern. EEG findings can vary, seizures may be incompletely witnessed, medication can change the visible pattern and some syndromes overlap clinically. The expected age range can also be broader than people assume.
The correct approach is not to force every person into a named syndrome. When criteria are not met, clinicians can still classify the seizure type and epilepsy type and continue investigating the cause.
The central point
An epilepsy syndrome is a pattern that brings multiple pieces of the diagnosis together. It can combine seizure types, EEG, age, development, imaging, genetics, comorbidities and natural history into a more specific clinical picture.
For some people that extra precision changes treatment and prognosis. For others, no named syndrome is ever identified — and that does not make their epilepsy less genuine.
Where next?
What Is Epilepsy? →
Seizure Types →
Diagnosis and Tests →
Genetics & Epilepsy →
Treatment Options →
Back to Understanding Epilepsy →
Reflex and photosensitive syndrome
Photosensitive Occipital Lobe Epilepsy →
Aetiology-specific syndrome
Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis →
Sources
- International League Against Epilepsy — Classification and Definition of Epilepsy Syndromes
- ILAE — Classification of the Epilepsies
- NICE NG217 — Epilepsies in children, young people and adults
Medical note: This page is for education and awareness and does not replace specialist diagnosis. Epilepsy syndrome classification should be based on the full clinical and EEG picture and may change as new information becomes available.